In April, beleaguered blood-testing company Theranos Inc laid off most of its workforce. Theranos and its CEO Elizabeth Holmes agreed to settle fraud charges with the US Securities and Exchange Commission, with Holmes surrendering voting control over the company she established, returning millions of shares to the privately held company…